GelMEDIX was founded in 2020 based upon work from Dr. Reza Dana from Massachusetts Eye and Ear and Harvard Medical School and Dr. Nasim Annabi from UCLA. GelMEDIX is developing its novel bioadhesives platform to provide new solutions for ocular drug delivery.
- Noel Vera-Gonzalez Biomaterials Scientist
- Arthur Speros Engineer 1
- Max Cotler Sr. Manager Corporate Development & Operations
- Art Driscoll Chief Development Officer